4
Changes in Ownership
Xilio Therapeutics, Inc. Filed Acc 0001062993-25-011170
Options or other derivatives
- 10% owner bought 53,340,000 shares
From the SEC's structured data for this filing
Trades in this filing
GILEAD SCIENCES, INC. · 10% owner
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-06-05 | Purchase : show line 1 in the form Prefunded Warrants (right to buy) | +13,335,000 | 23,310,266 | D |
| 2025-06-05 | Purchase : show line 2 in the form Series A Warrants (right to buy) | +13,335,000 | 13,335,000 | D |
| 2025-06-05 | Purchase : show line 3 in the form Series B Warrants (right to buy) | +13,335,000 | 13,335,000 | D |
| 2025-06-05 | Purchase : show line 4 in the form Series C Warrants (right to buy) | +13,335,000 | 13,335,000 | D |
Loading xslF345X05/form4.xml…